Aehr Test Systems (AEHR) Q4 2026 earnings review
A Massive AI Inflection Point, But Dilution Funded the Runway
Aehr Test Systems just delivered a watershed quarter. After navigating a brutal EV slowdown that stalled its legacy Silicon Carbide (SiC) business, Aehr's pivot to Artificial Intelligence testing is accelerating rapidly. Q4 revenue of $18.8M reversed three quarters of stagnation, but the real story is bookings: a record $60.7M in the quarter drove the effective backlog to an unprecedented $100.6M. Management issued blockbuster FY27 guidance of $130M-$150M in revenue, representing 160%-200% YoY growth. However, beneath the operational triumph lies a financial reality check: the company's massive $116.5M cash pile wasn't generated by operations, but by heavy shareholder dilution via a $97.4M stock issuance.
🐂 Bull Case
With an effective backlog of $100.6M heading into FY27, Aehr has effectively de-risked the majority of its massive $140M (midpoint) revenue target. The transition from erratic, lumpy orders to sustained, high-volume production demand is materializing.
The successful benchmark of the FOX WLBI solution with a top-tier AI processor supplier proves that Aehr's wafer-level testing yields superior economics for multi-chip packages (like CoWoS) over traditional package-level burn-in.
🐻 Bear Case
While total cash looks phenomenal at $116.5M, operating cash flow for the year was negative $3.3M. The cash surge was entirely funded by issuing over 3.3 million shares via ATM programs, significantly diluting existing shareholders ahead of the growth curve.
Despite the massive numbers, the backlog is highly concentrated among a few lead hyperscalers and top-tier processor suppliers. Any delay in facility readiness or supply chain bottlenecks at a single customer could severely derail quarterly targets.
⚖️ Verdict: 🟢
Bullish. The scale of the FY27 guidance and the secured backlog simply outweigh the very real dilution concerns. Aehr has successfully caught the AI hardware wave just as its legacy EV market begins to show a pulse again.
Key Themes
Wafer-Level AI Processor Adoption Accelerating
Demand for the FOX WLBI solution is accelerating as AI applications scale. Aehr's lead AI production customer is shifting entirely from system-level to wafer-level burn-in for their accelerators. Most critically, Aehr successfully completed a highly anticipated benchmark test with another top-tier AI processor supplier, which is now moving toward pilot production. This transition from validation to deployment is the primary engine behind the 160%+ growth forecast.
Package-Level (Sonoma) Gaining Heavy Hyperscaler Traction
Aehr's acquisition of InCal is paying massive dividends. A premier hyperscale data center customer placed record follow-on production orders for the Sonoma system. Crucially, this customer is expanding purchases for a second-generation device with double the power requirements of the first, perfectly aligning with Aehr's high-power competitive moat.
Silicon Photonics and SiC Stabilizing
While AI is the star, secondary markets are waking up. Silicon photonics (crucial for optical I/O in AI data centers) is accelerating with follow-on orders. Meanwhile, the battered Silicon Carbide (SiC) segment showed a pulse: Aehr secured $8M in new orders in just the last month, driven by global EV programs and automotive qualification, hinting that the worst of the macro EV slump may be priced in.
Cash Flush, But Operations Bled Cash
Aehr proudly highlighted an ending cash balance of $116.5M (up from $37.1M last quarter). However, a look under the hood contradicts the notion of internal cash generation. Full-year operating cash flow was actually negative $3.3M. The company padded its balance sheet by heavily tapping its public offering programs, raising $97.4M net of issuance costs in FY26. Diluted shares jumped from 29.8M a year ago to 33.1M today.
Gross Margin Lags The Revenue Rebound
Despite Q4 revenue surging 33% YoY, GAAP gross profit actually fell sequentially and YoY in percentage terms due to product mix and scale ramp-up costs. Non-GAAP Gross Profit was $8.4M on $18.8M of sales (44.8%), which is a decent sequential recovery from the 30% ranges seen in Q2/Q3, but still trails the 50%+ margins Aehr enjoyed during the peak SiC boom in early FY24. Execution on margin will be critical to hitting FY27 targets.
Other KPIs
Reversing. Snapped a multi-quarter streak of unprofitability. Non-GAAP EPS came in at $0.11, a drastic improvement from the $(0.05) seen in Q3 and $(0.01) a year ago. Excludes $1.6M in stock-based compensation and minor acquisition-related costs.
An improvement over the $(7.4) million usage in FY25, but still negative. The massive scale-up in inventory ($41.3M remaining flat YoY despite revenue drops) shows the company has been pre-building for the anticipated AI surge.
Guidance
Accelerating violently. This represents 160% to 200% year-over-year growth from the $50.0M achieved in FY26. Backed by $100.6M in effective backlog, this is one of the most aggressive growth profiles in the semiconductor test equipment space today.
Accelerating. At the midpoint ($140M revenue), this implies approximately $28M in Non-GAAP Net Income for the year. Compared to the meager $0.9M Non-GAAP net income generated in all of FY26, this represents an explosive reversal in profitability driven by immense operating leverage as volume scales.
Key Questions
Capacity Constraints for $150M Output
With the explosive guide to $130M-$150M, how quickly can the new contract manufacturer scale Sonoma production, and are there any single points of failure in the supply chain (e.g., WaferPaks) that could bottleneck deliveries?
Backlog Concentration
Of the $100.6M effective backlog, what is the approximate percentage split between your lead AI hyperscale customer and the rest of the market? How heavily weighted is it toward Sonoma vs. FOX WLBI?
Capital Allocation Plan
After raising nearly $100M via ATM offerings to reach $116M in cash, is this capital meant strictly as a working capital buffer for the massive FY27 ramp, or are you exploring M&A opportunities in the advanced packaging space?